...
首页> 外文期刊>European urology >Systematic review of perioperative and quality-of-life outcomes following surgical management of localised renal cancer
【24h】

Systematic review of perioperative and quality-of-life outcomes following surgical management of localised renal cancer

机译:局限性肾癌手术治疗后围手术期和生活质量预后的系统评价

获取原文
获取原文并翻译 | 示例
           

摘要

Context: For the treatment of localised renal cell carcinoma (RCC), uncertainties remain over the perioperative and quality-of-life (QoL) outcomes for the many different surgical techniques and approaches of nephrectomy. Controversy also remains on whether newer minimally invasive nephron-sparing interventions offer better QoL and perioperative outcomes, and whether adrenalectomy and lymphadenectomy should be performed simultaneously with nephrectomy. These non-oncological outcomes are important because they may have a considerable impact on localised RCC treatment decision making. Objective: To review systematically all the relevant published literature comparing perioperative and QoL outcomes of surgical management of localised RCC (T1-2N0M0). Evidence acquisition: Relevant databases including Medline, Embase, and the Cochrane Library were searched up to January 2012. Randomised controlled trials (RCTs) or quasi-randomised controlled trials, prospective observational studies with controls, retrospective matched-pair studies, and comparative studies from well-defined registries/databases were included. The outcome measures were QoL, analgesic requirement, length of hospital stay, time to normal activity level, surgical morbidity and complications, ischaemia time, renal function, blood loss, length of operation, need for blood transfusion, and perioperative mortality. The Cochrane risk of bias tool was used to assess RCTs, and an extended version was used to assess nonrandomised studies (NRSs). The quality of evidence was assessed using Grading of Recommendations, Assessment, Development, and Evaluation. Evidence synthesis: A total of 4580 abstracts and 380 full-text articles were assessed, and 29 studies met the inclusion criteria (7 RCTs and 22 NRSs). There were high risks of bias and low-quality evidence for studies meeting the inclusion criteria. There is good evidence indicating that partial nephrectomy results in better preservation of renal function and better QoL outcomes than radical nephrectomy regardless of technique or approach. Regarding radical nephrectomy, the laparoscopic approach has better perioperative outcomes than the open approach, and there is no evidence of a difference between the transperitoneal and retroperitoneal approaches. Alternatives to standard laparoscopic radical nephrectomy (LRN) such as hand-assisted, robot-assisted, or single-port techniques appear to have similar perioperative outcomes. There is no good evidence to suggest that minimally invasive procedures such as cryotherapy or radiofrequency ablation have superior perioperative or QoL outcomes to nephrectomy. Regarding concomitant lymphadenectomy during nephrectomy, there were low event rates for complications, and no definitive difference was observed. There was no evidence to base statements about concomitant ipsilateral adrenalectomy during nephrectomy. Conclusions: Partial nephrectomy results in significantly better preservation of renal function over radical nephrectomy. For tumours where partial nephrectomy is not technically feasible, there is no evidence that alternative procedures or techniques are better than LRN in terms of perioperative or QoL outcomes. In making treatment decisions, perioperative and QoL outcomes should be considered in conjunction with oncological outcomes. Overall, there was a paucity of data regarding QoL outcomes, and when reported, both QoL and perioperative outcomes were inconsistently defined, measured, or reported. The current evidence base has major limitations due to studies of low methodological quality marked by high risks of bias.
机译:背景:对于局限性肾细胞癌(RCC)的治疗,对于许多不同的肾切除术和手术方法,围手术期和生活质量(QoL)结果仍然存在不确定性。对于较新的微创保留肾单位的干预措施能否提供更好的QoL和围手术期效果,以及是否应在进行肾脏切除术时同时进行肾上腺切除术和淋巴结切除术,仍存在争议。这些非肿瘤学结果非常重要,因为它们可能会对局部RCC治疗决策产生重大影响。目的:系统地回顾所有相关出版文献,比较局部RCC(T1-2N0M0)的围手术期和QoL结局。证据收集:截至2012年1月,检索了包括Medline,Embase和Cochrane库在内的相关数据库。随机对照试验(RCT)或准随机对照试验,具有对照的前瞻性观察性研究,回顾性配对研究以及来自包括定义明确的注册表/数据库。结果指标包括生活质量,镇痛要求,住院时间,达到正常活动水平的时间,手术发病率和并发症,缺血时间,肾功能,失血量,手术时间,输血需要量和围手术期死亡率。使用Cochrane偏倚风险工具评估RCT,并使用扩展版本评估非随机研究(NRS)。使用建议分级,评估,制定和评估来评估证据的质量。证据综合:总共评估了4580篇摘要和380篇全文文章,有29项研究符合纳入标准(7篇RCT和22篇NRS)。符合纳入标准的研究存在较高的偏倚风险和低质量的证据。有充分的证据表明,无论采用何种技术或方法,部分肾切除术均比根治性肾切除术能更好地保留肾脏功能和改善QoL结果。关于根治性肾切除术,腹腔镜手术的围手术期结局优于开放手术,并且没有证据表明腹膜后和腹膜后入路之间存在差异。标准的腹腔镜根治性肾切除术(LRN)的替代方法,例如手助,机器人辅助或单端口技术,似乎具有相似的围手术期效果。没有充分的证据表明,微创手术(例如冷冻疗法或射频消融)比肾切除术具有更好的围手术期或QoL结果。关于在肾切除术中同时进行的淋巴结清扫术,并发症发生率较低,并且没有观察到确切的差异。没有证据表明在肾脏切除术中同时进行同侧肾上腺切除术。结论:部分肾切除术比保留肾切除术能更好地保留肾脏功能。对于部分肾切除术在技术上不可行的肿瘤,没有证据表明在围手术期或QoL结果方面替代手术或技术优于LRN。在做出治疗决策时,应将围手术期和QoL结果与肿瘤学结果结合考虑。总体而言,关于QoL结果的数据很少,当报告时,QoL和围手术期结果的定义,测量或报告均不一致。由于研究方法学质量低下,偏倚风险高,目前的证据基础存在主要局限性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号